Advanced Cell Technology, Inc.

Biotech firm files 8-K/A with U.S. SEC

Published in Lab Business Week, May 22nd, 2005

Advanced Cell Technology, Inc., (ACTH.OB), a biotechnology company applying stem cell technology in the emerging field of regenerative medicine, announced that the company has filed Form 8-K/A with the U.S. Securities and Exchange Commission (SEC).

This document, required by the SEC, discloses the company's financial statements for periods ending December 31, 2004.

"This is an important step for Advanced Cell Technology - our timely filing on Form 8K of financial statements required following our recent merger transaction," said James Stewart, chief financial officer of Advanced Cell Technology.

"ACT looks forward to providing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2005-05-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry